Pyomyositis of extraocular muscle: Case series and review of the literature

Acharya, Ishan G.; Jethani, Jitendra
November 2010
Indian Journal of Ophthalmology;Nov2010, Vol. 58 Issue 6, p532
Academic Journal
Case Study
Pyomyositis is a primary acute bacterial infection usually caused by Staphylococcus aureus. Any skeletal muscle can be involved, but the thigh and trunk muscles are commonly affected. Only three cases of extraocular muscle (EOM) pyomyositis have been reported. We herein present four cases of isolated EOM pyomyositis. Three of our cases presented with acute onset of proptosis, pain, swelling and redness. One patient presented with mass in the inferior orbit for 4 months. One patient had central retinal artery occlusion on presentation. None of them had marked systemic symptoms. Computed tomography scan of all patients showed a typical hypodense rim enhancing lesion of the muscle involved. Three patients were started on intravenous antibiotics immediately on diagnosis and the pus was drained externally. Two patients underwent exploratory orbitotomy. In conclusion, it should be considered in any patient presenting with acute onset of orbital inflammation. Management consists of incision and drainage coupled with antibiotic therapy.


Related Articles

  • New antibiotic seen as more effective in fighting bacteria. Edelson, Ed // Ophthalmology Times;4/1/2002, Vol. 27 Issue 7, p46 

    Presents information on the effectiveness of the fluoroquinolone Levofloxacin in fighting bacteria. Tests made on several fluoroquinolones; Serious infections treated by levofloxacin; Length of use of fluoroquinolones or antibiotics.

  • Antibiotics changed our outlook on life. Newport, Alan // American Agriculturist (0161-8237);Jun2011, Vol. 208 Issue 6, pBP2 

    The article offers information on the benefits offered by antibiotics to fight bacterial infections in both human and animals.

  • Use of antibiotics: treatment of neonatal bacterial infection. Davies, Pamela A. // British Medical Journal;9/2/1978, Vol. 2 Issue 6138, p676 

    Examines the use of antibiotics in the treatment of neonatal bacterial infection. Difficulties of diagnosis in neonatal period; Treatments used for suspected major infections; Suggested dosage of drugs for neonatal bacterial infections.

  • Cefotaxime Compared with Nafcillin Plus Tobramycin for Serious Bacterial Infections. Smith, Craig R.; Ambinder, Richard; Lipsky, James J.; Petty, Brent G.; Israel, Elliot; Levitt, Roy; Mellits, E. David; Rocco, Laura; Longstreth, James; Lietman, Paul S. // Annals of Internal Medicine;Oct84, Vol. 101 Issue 4, p469 

    Focuses on a study which compared the effectiveness of several antibiotics in the treatment of serious bacterial infections. Methods; Results; Discussion.

  • Antibiotics changed our outlook on life. Newport, Alan // Western Farmer-Stockman;Jun2011, Vol. 134 Issue 6, pBP2 

    The article offers the author's insights regarding the benefits of antibiotics in the treatment of bacterial infections on human and animals.

  • with medication.  // Better Homes & Gardens;Jun2015, Vol. 93 Issue 6, p160 

    The article offers information on careful consideration with medication focusing on the use and effectiveness of antibiotics which have the potential to affect the balance of bacteria.

  • Nature: Toward an alternative for antibiotics to fight bacterial infections?  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article discusses the use of therapeutic drugs as an alternative of antibiotics for the treatment of bacterial infections.

  • Antibiotics.  // Review of Optometry;6/15/2003 Supplement, Vol. 140, p2A 

    Focuses on the antibacterials for bacterial ocular infections. Three categories of drugs employed to treat eye infections; Most popular commercial brands of fluoroquinolones; Aminoglycosides; Erythromycin; Bacitracin ophthalmic ointment; Polymxin B combinations; Sulfa drugs and chloramphenicol....

  • New Approaches for Anti-Infective Drug Discovery: Antibiotics, Vaccines and Beyond. Cheng, Q.; Wang, S.; Salyers, A.A. // Current Drug Targets - Infectious Disorders;Mar2003, Vol. 3 Issue 1, p65 

    Infectious disease is the leading cause of death worldwide, and billions of dollars are invested every year in developing anti-infective drugs. In the meantime, resistant bacteria are on the steady rise and render many once effective drugs useless. The tremendous funding and the urgent need to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics